Bayer highlights oncology ambitions in new Kendall Square labs

It’s been just a few months since Bayer opened its new $140 million oncology research and innovation center in Cambridge, MA, just down the road from its old Kendall Square digs. Now it’s all hands on deck to beef up the pipeline — and that means deals are coming, according to global oncology head Christine Roth.